PK and Safety of SI-722 in IC/BPS

Status:
Completed

Trial end date:
2021-01-12

Target enrollment:

Participant gender:

This study is designed randomized, double-blind, placebo-controlled trial in Interstitial Cystitis/Bladder Pain Syndrome patients.

Phase 1/Phase 2

Seikagaku Corporation